Arvinas, Inc. (ARVN)
13.18
+0.81
(+6.55%)
USD |
NASDAQ |
Feb 25, 14:08
Arvinas Profit Margin (Quarterly) : -709.5% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | -9.34% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -5.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -14.28% |
| Return on Assets | -8.85% |
| Return on Invested Capital | -14.04% |
| Operating Margin (Quarterly) | -754.7% |
| Return on Net Operating Assets | -390.7% |